Becton, Dickinson and Company · Class II · Cleared Mar 15, 2024
| K-number | K233986 |
| Device name | BD Phoenix Automated Microbiology System - GN Ciprofloxacin (0.01564 µg/mL) |
| Applicant | Becton, Dickinson and Company |
| Product code | LON |
| Device class | Class II |
| Decision date | Mar 15, 2024 |
| Decision | Substantially Equivalent |
| Regulation | 866.1645 |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov